Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/-) mice showed no memory enhancement but hyposensitivity to amnesic drugs

被引:9
作者
Espallergues, Julie
Galvan, Laurie [2 ]
Sabatier, Florence [2 ,3 ,4 ]
Rana-Poussine, Vanessa [3 ,4 ]
Maurice, Tangui [2 ]
Chatonnet, Arnaud [1 ,3 ,4 ]
机构
[1] Univ Montpellier 2, INSERM, U710, F-34095 Montpellier 5, France
[2] EPHE, F-75017 Paris, France
[3] INRA, UMR 866, F-34060 Montpellier, France
[4] Univ Montpellier 1, F-34967 Montpellier, France
关键词
Acetylcholinesterase; Learning and memory; Amyloid toxicity; Scopolamine; Knockout model; AMYLOID-BETA-PEPTIDE; ALPHA-7 NICOTINIC RECEPTOR; NEURONAL CELL LOSS; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; BETA(25-35) PEPTIDE; OXIDATIVE STRESS; RAT HIPPOCAMPUS; SENILE-DEMENTIA; IN-VITRO;
D O I
10.1016/j.bbr.2009.09.024
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Decrease in the expression or activity of acetylcholinesterase (ACH) enzymatic activity results in increased cholinergic tonus in the brain and periphery, with concomitant regulations of nicotinic and muscarinic receptors expression. We generated AChE knockout mice and characterized the behavioral phenotype of heterozygous animals, focusing on learning and memory functions. Male and female, AChE(+/-) and AChE(+/+) littermate controls (129sv strain) were tested at 5-9 weeks of age. AChE activity was significantly decreased in the hippocampus and cortex of AChE(+/-) mice, but butyrylcholinesterase activity was preserved. AChE(+/-) mice failed to show any difference in terms of locomotion, exploration and anxiety parameters in the open-field test. Animals were then tested for place learning in the water-maze. They were trained using a 'sustained acquisition' protocol (3 swim trials per day) or a 'mild acquisition' protocol (2 swim trials per day) to locate an invisible platform in fixed position (reference memory procedure). Then, during 3 days, they were trained to locate the platform in a variable position (working memory procedure). Learning profiles and probe test performances were similar for AChE(+/-) and AChE(+/+) mice. Mice were then treated with the muscarinic receptor antagonist scopolamine (0.5, 5 mg/kg) 20 min before each training session. Scopolamine impaired learning at both doses in AChE(+/+) mice, but only at the highest dose in AChE(+/-) mice. Moreover, the intracerebroventricular injection of amyloid-beta(25-35) peptide, 9 nmol, 7 days before water-maze acquisition, failed to induce learning deficits in AChE(+/-) mice, but impaired learning in AChE(+/+) controls. The peptide failed to be toxic in forebrain structures of AChE(+/-) mice, since an increase in lipid peroxidation levels was measured in the hippocampus of AChE(+/+) but not AChE(+/-) mice. We conclude that the increase in cholinergic tonus observed in AChE(+/-) mice did not result in increased memory functions but allowed a significant prevention of the deleterious effects of muscarinic blockade or amyloid toxicity. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:263 / 273
页数:11
相关论文
共 59 条
[1]   A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25-35 [J].
Alkam, Tursun ;
Nitta, Atsumi ;
Mizoguchi, Hiroyuki ;
Itoh, Akio ;
Nabeshima, Toshitaka .
BEHAVIOURAL BRAIN RESEARCH, 2007, 180 (02) :139-145
[2]  
Alvarez A, 1998, J NEUROSCI, V18, P3213
[3]   Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells:: Role of nicotinic receptors [J].
Arias, E ;
Gallego-Sandín, S ;
Villarroya, M ;
García, AG ;
López, MG .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1346-1353
[4]   Receptor-mediated tobacco toxicity:: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of α7 nicotinic receptor in oral keratinocytes [J].
Arredondo, Juan ;
Chernyavsky, Alexander I. ;
Jolkovsky, David L. ;
Pinkerton, Kent E. ;
Grando, Sergei A. .
FASEB JOURNAL, 2006, 20 (12) :2093-2101
[5]   Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection [J].
Buckingham, Steven D. ;
Jones, Andrew K. ;
Brown, Laurence A. ;
Sattelle, David B. .
PHARMACOLOGICAL REVIEWS, 2009, 61 (01) :39-61
[6]   Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment [J].
Butterfield, D. Allan ;
Reed, Tanea ;
Newman, Shelley F. ;
Sultana, Rukhsana .
FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (05) :658-677
[7]   Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus [J].
Chacón, MA ;
Reyes, AE ;
Inestrosa, NC .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (01) :195-204
[8]   Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies [J].
Crawley, JN ;
Belknap, JK ;
Collins, A ;
Crabbe, JC ;
Frankel, W ;
Henderson, N ;
Hitzemann, RJ ;
Maxson, SC ;
Miner, LL ;
Silva, AJ ;
Wehner, JM ;
WynshawBoris, A ;
Paylor, R .
PSYCHOPHARMACOLOGY, 1997, 132 (02) :107-124
[9]   β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors:: In vitro and in vivo mechanisms related to Alzheimer's disease [J].
Dineley, KT ;
Westerman, M ;
Bui, D ;
Bell, K ;
Ashe, KH ;
Sweatt, JD .
JOURNAL OF NEUROSCIENCE, 2001, 21 (12) :4125-4133
[10]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&